ArticleEuropean journal of medical research2025
The prognostic values of the SII and the SIRI in patients with STEMI following percutaneous coronary intervention: a retrospective study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Early Inflammatory Biomarkers, Ventricular Dysfunction and In-Hospital Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.Diagnostics (Basel, Switzerland) · 2026Article
- The systemic immune-inflammation index in coronary heart disease: a narrative review of thromboinflammation, phenotype-dependent utility, and clinical translation.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAlthough systemic immune-inflammation index (SII) and the systemic inflammation response index (SIRI) have garnered attention as novel inflammatory response markers in various clinical contexts, their application in patients with ST-segment elevation myocardial infarction (STEMI) following percutaneous coronary intervention (PCI) remains unclear. This study aims to fill this gap by investigating and validating the relationships between SII, SIRI, and the risks for all-cause mortality and major adverse cardiovascular events (MACEs) in this specific patient population.
methods1222 participants diagnosed with STEMI and who underwent urgent PCI were included in the study. Cox proportional hazards regression analyses were employed to analyze the association between log
resultsAfter a 1-year follow-up, 106 experienced all-cause mortality, and 163 experienced MACEs. Higher levels of log
conclusionsLog
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.